Abstract
Type 1 parathyroid hormone receptor (PTH1R) activation, desensitization, internalization, and recycling proceed in a cyclical manner. The Na+/H+ exchange regulatory factor 1 (NHERF1) is a cytoplasmic adapter protein that regulates trafficking and signaling of several G protein-coupled receptors (GPCRs) including the PTH1R. The mineral ion wasting and bone phenotype of NHERF1-null mice suggests that PTH1R may interact with NHERF1. The objective of this study was to examine the effect of NHERF1 on PTH1R desensitization. Using rat osteosarcoma T6-N4 cells expressing the endogenous PTH1R, in which NHERF1 expression could be induced by tetracycline, PTH1R desensitization was assessed by measuring adenylyl cyclase activity after successive PTH challenges. PTH1R-mediated adenylyl cyclase responses were desensitized by repetitive PTH challenges in a concentration-dependent manner, and desensitization was inhibited by NHERF1. NHERF1 blocked PTH-induced dissociation of the PTH1R from Gαs. Blocking PTH1R endocytosis did not mitigate PTH1R desensitization. Reducing constitutive NHERF1 levels in human osteosarcoma SAOS2 cells, which express both endogenous PTH1R and NHERF1, with short hairpin RNA directed against NHERF1 restored PTH1R desensitization. Mutagenesis of the PDZ-binding domains or deletion of the NHERF1 MERM domain demonstrated that both are required for inhibition of receptor desensitization. A phosphorylation-deficient PTH1R exhibited reduced desensitization and interaction with β-arrestin2 compared with wild-type PTH1R. NHERF1 inhibited β-arrestin2 binding to wtPTH1R but had no effect on β-arrestin2 association with pdPTH1R. Such an effect may protect against PTH resistance or PTH1R down-regulation in cells harboring NHERF1.
Footnotes
-
This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grants DK69998, DK063211, DK11794].
-
ABBREVIATIONS: PTH, parathyroid hormone; PTHrP, parathyroid hormone-related peptide; PTH1R, type 1 PTH receptor; GPCR, G protein-coupled receptor; GRK2, G protein-coupled receptor kinase 2; NHERF1, Na+/H+ exchange regulatory factor 1; PDZ, postsynaptic density 95/discs large/zona occludens; MERM, merlin-ezrin-radixin-moesin; GFP, green fluorescent protein; BSA, bovine serum albumin; ROS, rat osteosarcoma; shRNA, short hairpin RNA; siRNA, small interfering RNA; IBMX, 3-isobutyl-1-methylxanthine; Tet, tetracycline; wtPTH1R, wild-type PTH1R; PKC, protein kinase C; PD, phosphorylation deficient; HA, hemagglutinin.
-
↵
The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
- Received December 26, 2008.
- Accepted February 2, 2009.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|